We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
-15.67%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$4.98B
AUM Growth
-$1.04B
Cap. Flow
+$50.1M
Cap. Flow %
1.01%
Top 10 Hldgs %
30.66%
Holding
1,260
New
93
Increased
866
Reduced
230
Closed
68
Avg Time Held
6.6 quarters
Top 10 Avg Time Held
6.3 quarters
Top 20 Avg Time Held
4.9 quarters

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$40.1M
2
PG icon
Procter & Gamble
PG
+$19.2M
3
MRK icon
Merck
MRK
+$12.2M
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$10.3M
5
IBM icon
IBM
IBM
+$9.7M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$37.9M
2
AAPL icon
Apple
AAPL
+$19.7M
3
MSFT icon
Microsoft
MSFT
+$14.9M
4
HD icon
Home Depot
HD
+$14.7M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$8.67M

Sector Composition

Rank Sector Weight
1 Technology 29.34%
2 Healthcare 13.95%
3 Consumer Discretionary 12.19%
4 Financials 10.87%
5 Communication Services 8.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
CTLT icon
351
DELISTED
CATALENT, INC.
CTLT
$2.25M 0.05%
20,937
+5,243
+33% +$534K
2020 Q2
8 quarters
FRC
352
DELISTED
First Republic Bank
FRC
$2.2M 0.04%
15,234
+3,597
+31% +$539K
2020 Q2
8 quarters
PTC icon
353
PTC
PTC
$21.1B
$2.17M 0.04%
20,361
+2,759
+16% +$298K
2020 Q2
8 quarters
GLW icon
354
Corning
GLW
$128B
$2.16M 0.04%
68,561
-6,195
-8% -$213K
2020 Q2
8 quarters
NDAQ icon
355
Nasdaq
NDAQ
$52.3B
$2.16M 0.04%
42,465
+8,124
+24% +$430K
2020 Q2
8 quarters
ABMD
356
DELISTED
Abiomed Inc
ABMD
$2.16M 0.04%
8,717
+1,200
+16% +$324K
2020 Q2
8 quarters
AME icon
357
Ametek
AME
$57.4B
$2.15M 0.04%
19,561
+4,579
+31% +$557K
2020 Q2
8 quarters
TTD icon
358
Trade Desk
TTD
$5.75B
$2.15M 0.04%
51,325
+1,739
+4% +$95.2K
2020 Q2
8 quarters
AVTR icon
359
Avantor
AVTR
$10.5B
$2.1M 0.04%
67,369
-1,837
-3% -$57.3K
2020 Q2
8 quarters
CRL icon
360
Charles River Laboratories
CRL
$14.3B
$2.09M 0.04%
9,775
+1,516
+18% +$370K
2020 Q2
8 quarters
DTE icon
361
DTE Energy
DTE
$26.7B
$2.09M 0.04%
16,508
+3,955
+32% +$516K
2020 Q2
8 quarters
AVY icon
362
Avery Dennison
AVY
$12.9B
$2.09M 0.04%
12,900
+2,404
+23% +$411K
2020 Q2
8 quarters
HII icon
363
Huntington Ingalls Industries
HII
$10.2B
$2.09M 0.04%
9,581
-12,252
-56% -$2.59M
2020 Q2
8 quarters
ALNY icon
364
Alnylam Pharmaceuticals
ALNY
$29.9B
$2.09M 0.04%
14,303
+520
+4% +$73.8K
2020 Q2
8 quarters
APO icon
365
Apollo Global Management
APO
$68.7B
$2.09M 0.04%
43,028
+14,225
+49% +$774K
2022 Q1
1 quarter
STT icon
366
State Street
STT
$47.8B
$2.08M 0.04%
33,755
+7,859
+30% +$556K
2020 Q2
8 quarters
ZBRA icon
367
Zebra Technologies
ZBRA
$18.3B
$2.07M 0.04%
7,044
-2,114
-23% -$736K
2020 Q2
8 quarters
EIX icon
368
Edison International
EIX
$21.3B
$2.04M 0.04%
32,225
+7,533
+31% +$511K
2020 Q2
8 quarters
NBIX icon
369
Neurocrine Biosciences
NBIX
$13.7B
$2.03M 0.04%
20,865
+537
+3% +$49.6K
2020 Q2
8 quarters
BF.B icon
370
Brown-Forman Class B
BF.B
$12.5B
$2.03M 0.04%
28,957
+5,869
+25% +$393K
2020 Q2
8 quarters
MRO icon
371
DELISTED
Marathon Oil Corporation
MRO
$2.02M 0.04%
89,854
-113,925
-56% -$3.05M
2020 Q2
8 quarters
NVR icon
372
NVR
NVR
$15.4B
$2M 0.04%
500
+70
+16% +$298K
2020 Q2
8 quarters
AEE icon
373
Ameren
AEE
$28.9B
$2M 0.04%
22,093
+5,459
+33% +$505K
2020 Q2
8 quarters
CTRA icon
374
DELISTED
Coterra Energy
CTRA
$1.99M 0.04%
77,319
+11,527
+18% +$350K
2020 Q2
8 quarters
HZNP
375
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$1.98M 0.04%
24,838
+18,124
+270% +$1.72M
2020 Q2
8 quarters
13 14
15
16 17

Similar funds

PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
BS
Banco Santander Madrid, Spain $16.1B AUM 35.02% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $16.1B AUM 40.83% 1-Year Est. Return
NMO
Newlands Management Operations Dallas, Texas $16.6B AUM 3.91% 1-Year Est. Return
PAS
Park Avenue Securities New York $16B AUM 26.77% 1-Year Est. Return

Xponance's Q2 2022 Portfolio in Review

As of Q2 2022, Xponance held 1,260 positions worth $4.98B, down 17% from $6.01B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Xponance's Q2 2022 filing shows 93 new, 866 increased, 230 reduced and 68 closed positions. Its largest new stake was Warner Bros: 370,598 shares worth $4.97M. The largest sale was Meta Platforms (Facebook), an estimated $37.9M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Xponance's largest Q2 2022 buy was Warner Bros: 370,598 shares worth $4.97M.
  • Xponance added most to UnitedHealth in Q2 2022, an estimated $40.1M increase.
  • Xponance's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $37.9M.
  • Xponance fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $2.36M.
  • Xponance's ten largest holdings make up 31% of its $4.98B portfolio in Q2 2022.
  • Xponance opened 93 new positions and closed 68 in Q2 2022.
  • Xponance's portfolio value fell 17% quarter-over-quarter to $4.98B.

Based on Xponance's 13F filing for Q2 2022, filed 2 Aug 2022.